B
CBPO

Barings’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Barings’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-117,080
Closed -$11.7M – 1044
2017
Q1 		$11.7M Buy
+117,080
New +$12.5M 0.13% 138

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Barings's CBPO Position: Q2 2017 in Review

Barings sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 117,080 shares — an estimated $11.7M sold.

Barings first reported a position in CBPO in Q1 2017 and held it in 1 quarter. The position peaked at $11.7M in Q1 2017. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

  • Barings reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
  • Barings sold 117,080 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $11.7M.
  • Barings first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 1 quarter.
  • Barings's China Biologic Products Holdings, Inc. position peaked at $11.7M in Q1 2017.
  • 119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Barings's 13F filing for Q2 2017, filed 14 Aug 2017.